-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HjXe3CHLj6JxOXtBcj9kONYcm7oo58HZ+bMuriS8uXOkVkEXtwzsaOxX7kKdS+Xf ldQbtFkGFZqUF0+fyk2INw== 0001144204-04-006260.txt : 20040511 0001144204-04-006260.hdr.sgml : 20040511 20040511090535 ACCESSION NUMBER: 0001144204-04-006260 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20040511 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYTHIAM INC CENTRAL INDEX KEY: 0001136174 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 880464853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31932 FILM NUMBER: 04795007 BUSINESS ADDRESS: STREET 1: 11150 SANTA MONICA BOULEVARD STREET 2: SUITE 1500 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310 444 4300 MAIL ADDRESS: STREET 1: 11150 SANTA MONICA BOULEVARD STREET 2: SUITE 1500 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: ALASKA FREIGHTWAYS INC DATE OF NAME CHANGE: 20010305 8-K 1 form8k.htm Unassociated Document

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

May 11, 2004

Date of Report (date of earliest event reported)

Hythiam, Inc.

Exact name of Registrant as Specified in its Charter


Delaware

333-58246

88-0464853

 State or Other Jurisdiction of Incorporation

 Commission File Number

 IRS Employer Identification Number


 
11150 Santa Monica Boulevard, Suite 1500, Los Angeles, California 90025

Address of Principal Executive Offices, Including Zip Code

(310) 444-4300

Telephone Number, Including Area Code

 
     

 

ITEM 9. REGULATION FD DISCLOSURE.

On May 11, 2004, Hythiam, Inc. issued a press release announcing that the company has licensed its proprietary HANDS Treatment Protocol™ to Lake Chelan Community Hospital of Washington. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
     
  HYTHIAM, INC.
 
 
 
 
 
 
Dated: May 11, 2004 By:   /s/ Chuck Timpe
 
Chuck Timpe, Chief Financial Officer
 

                   

 

EX-99 2 ex99.htm Unassociated Document

                                Press Release

 
Hythiam Contact:
Sanjay Sabnani
(310) 444-5335
ssabnani@hythiam.com
Media Contact:
Paul Wynn
(212) 586-8877
pwynn@belsitoco.com
Investment Community:
Budd Zuckerman
Genesis Select
(303) 415-0200
budd@genesisselect.com
        
HYTHIAM, INC. LICENSES PROPRIETARY HANDS™ ADDICTION TREATMENT
TO LAKE CHELAN COMMUNITY HOSPITAL

LOS ANGELES, CA—May 11, 2004— Hythiam, Inc. (AMEX: HTM), a healthcare services management company that focuses on alcohol and drug addiction treatment and neurostabilization to prevent craving and relapse, recently licensed its proprietary HANDS Treatment Protocol™ to Lake Chelan Community Hospital of Washington.
 
Located in Washington’s Lake Chelan Valley, Lake Chelan Community Hospital has an established Addiction Recovery Center that provides a comprehensive, holistic restorative program for adults suffering from alcohol and chemical dependency.
 
“We see Hythiam’s HANDS Treatment Protocol providing people in the Pacific Northwest with a cutting-edge addiction treatment to accelerate recovery from alcohol and drug dependence,” said Larry Peterson, CEO of Lake Chelan Community Hospital.
 
Hythiam’s HANDS Treatment Protocol ™ was designed for use by healthcare providers, enabling them to treat patients suffering from addictions to alcohol, cocaine, methamphetamine, and other addictive stimulants. Current results indicate the HANDS Treatment Protocol™ reduces inpatient treatment time, significantly reduces withdrawal symptoms, greatly improves treatment completion rates, increases cognitive function, eliminates cravings, and decreases patient relapse rates as compared to most current treatment options. Hythiam is in active negotiations to license the HANDS Treatment Protocol to additional hospitals and addiction treatment centers across the country.
 
"This agreement provides further evidence that the HANDS Treatment Protocol is filling an important unmet need, and that the healthcare community is recognizing its significant benefits,” said Terren S. Peizer, Chairman and CEO of Hythiam, Inc. “We are confident that this and future agreements will provide widespread access to the HANDS Treatment Protocol for those whose lives are impacted by alcohol and drug addiction.”
 
About HANDS™
 
Hythiam's HANDS Treatment Protocol™ is designed to treat addictions to alcohol, cocaine, and other addictive stimulants — as well as combinations of these drugs. HANDS™ is a medically supervised treatment protocol for neurostabilization and detoxification from alcohol and/or addictive psychostimulants that simultaneously eliminates cravings, enhances cognitive function, and facilitates a pain-free withdrawal resulting in accelerated recovery. Unlike current practices for withdrawing addicted patients from alcohol, cocaine, or other addictive stimulants, the HANDS protocols are completed within 2-3 consecutive days of inpatient treatment, eliminate the use of sedating medications, require no tapering or washout period, significantly reduce or eliminate withdrawal symptoms and have substantially higher completion rates.  HANDS protocols are specifically designed to eliminate cravings, a major factor in relapse.  By providing a more beneficial treatment of the physiological component of the disease, HANDS protocols offer patients an improved chance for recovery.
 
About Hythiam
 
Hythiam, Inc. is a healthcare services management company, formed for the purpose of researching, developing, licensing, and commercializing innovative technologies to improve the treatment of alcoholism and drug addiction. Hythiam's technology is focused on treating addiction at the source — the brain. Hythiam's proprietary, patented and patent-pending treatment protocols are designed to treat addiction by stabilizing neurological function.
 
Forward-Looking Statements
 
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations.  These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the healthcare industry; and additional risks discussed under the "Risk Factors" heading in Item 1 of Part I of the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2004.
 
# # #
GRAPHIC 3 g406870.jpg GRAPHIC begin 644 g406870.jpg M_]C_X``02D9)1@`!`0$!L`&P``#__@`R35),3%]'4D%02$E#4SI;2%E42$E! M35U(651(24%-7T903U]#35E+7TQ/1T\N15!3_]L`0P`'!08&!@4'!@8&"`@' M"0L2#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9&B4R)2@L+2\P+QTC-#@T M+CRD#\4]*WGS[$XZN/V=ENK M'PTN]=$V>X3LM['L*/3MA-%-2SSU#IGR$,P&@'&.9/N\ERUN73UI M%HF(E71WS4RS7+,[?-,:+B+/Q$M-=/'3U4$U&]Y#0YY#F9/;(Z?$A=NL-,E; MQO67KUM%N!$176$1$!$1`1$0$1$!$1`1$0$1$!$1`1$0$1$!$1!YSS14\+YI MGM9%&TNS',O71.C:2P0MJZD-FN;F^U)U;%^RW^_4K"U7KZFH3) M16?94U0R'3'G'&?=^L?L7.ZRUI/=I'6VSND91$[7/:"'SGR'<-]W4_8O2SZ) MAI*!]YU1*8*6%GB&F:<.QY./8_LCFO(S:G)GOTXN\_%VB8I7HQ1M$>]QM55W M&\U[75$LM55S.#&@\R2>C0.@^`6UGT7J6"F=4/MCMC1DALC7.`^`.5U/#RT- MNEWJ-4S4C*>E:XLH8&M`#0.60/<.6?,E2=(]D<;GO(:QHR2>P"B_HZM9VM;> M?>KAQ^)7KM]%93G!QUPK)VT2-M]*V7/B"%@=GKG:,J'=,VINHM7SU,<9%OCJ M'5+SCEMW$M;\_P!V5-:IH:3$39UT]=MY$1%O:1$1`1$0$1$!$1`1$0$1$!$1 M`1$0$1$!$6#>*M]%023QMR\8`ST!/=4R9*XZ3>W$=UJ5F]HK',LY:?55XCL5 MCJ;@\CQ&MVQ-/Z4A_!']?@"M=9;Q6SU\=/4.$C),C\$`M.,]ERFN))M3:PH= M+TKCX%.[=.X=B1EQ^3>7Q*KZ.U&/61UUXCG=37TOI8Z9]J>/J\^&5@DK:J35 M-VR\[W.@,GZ;\^U(?@>KM05>I[BRPV-CY*;?CV#^/([G]@>_X^2V> MM;J864VCM/1D2.#8I&Q?HMQRC!]XYD^7Q*V]GH+-H:SFJN-1$VJ>W[[*>;GG M]1@ZD?#KU*C49+ZO+T5X_>S%CQQCIT1/:.9>FEM*T&G*;UZL=')6ANZ2=_)L M0QS#<]![^I6@JYJCB#>&T5(98M-TC\S38QX[AY?T\AS/9?7AWG7\[72MEMVF MFNR&G\94X/\`SW#WE=[3P6ZR6UL438J2B@;W.&M'F2?WK72E--7:.?+\IB/& MC:.U//\`'FR::"&EIXZ>"-L<,;0QC&CDT#H%PFM+Y47*K&E+%]\J9CMJ)&GD MQO=N1T_:/ER[K\N6HKEJ2H?:-*QN$)]F:O<"UK1WQY?'KY#NNETQINAT_2^' M`/$J'C[[4.'M/_L/-TS21'+(&EX'7&?B%G+6W>QVF\M8VYT$-3L_!+QS;\".:;5GM M;A%IM$;TY:.EO.E:$U\M-5,]8I&OWL>[VG;>H9GKG'9<)I>]4EJM]WU#45,4 MU]K7N;#!G+F@G)<1V&>?P:%F<0=,V2R6^D^Y4$K*VIG$4;#,7-/GR)^`^:PK M'I6GO5^JZ:CGFCM](`U]1R<7R#D<:XS$Z;%X>*L>MQMV_S\L.7) MES9HZ^\Q]>7SI1]_=+45-IL[Y[E4$[KC5@B.-IZEN>1)/4\^G1=)#8[+1U/W M6UC?H+C7C'L2/'AL[@!HYGZL>Y;5W#^W/]F:ZW:1GZKJCE^Y9U!HG3=$X/9; MF3/'Z4[C)]AY?8K4ODQTZ,=8K\]^Z]=//]^_E_S[M94:W-6[U;3-IJ;A+T$A M861C_GR7S#I2Z7J1E3JRY.D:#N;14YVL;\3_`&Y^]=O%%%#&V.&-D;&]&M`` M'R"^U3P9M_)._DT=&_M3N\**CIJ&F92TD#(8&##6,&`%[HB[Q&W#H(B("(B` MB(@(N;O^M]):>,C;OJ"AII8_PH3*'2CEG\!N7?8MI8KM17VT4EWMTCI*.JC$ MD3G-+26GW'F$&P1$0$1$!$1`1$0$1$!$7(7_`(CZ)L#'FX:CH?$82TPP2>-( M".VUF2/F@Z]%CT%7!7T--74SBZ"HB;+&XC!+7`$'';D5D("(B"-N*F6UUFF` M)\".HE^!`;C[2%U>C;0+-8*:EV2UOWB!$12[B(B`B(@(B("(B`B( M@K?Z4UEM5+2VF\4U!!%<*JJ>V>H8W#Y0&#&X]\8'52KPEJ(*;A;IF2HFCAC] M38-TC@T9R>Y4=^EA^3^G_IDG\"U&F.$]RUSP[M5?>-33QR,I=MKI(V#P(&<] MN\=2YQZD<^G7&$%DH)H:B-LL$K)8W='L<'`_,+T53O1JN5SMW$"JT\^9_JLT M$HE@+CM;)&1AP'GU'S5L4!?(>P@D.&!UYKYGACJ()()6[HY&ECAG&01@JG?' M?14.A[_3&QMGI[+<8/8C\5[@R1G)SG]9DR:AH`<-V[.?$;C&<9[+!]'31,%'8J?65Q; M+)=:UKVTSG2N(BI^0`QTR=I///+&$$XK"O-3+1VBNJX-OBPT\DC-XR-P:2,C MRR%FKE.(]ON]QTM6PVB]_,$-'<`'F9'9<<=3[U;E56]*[\J[)]`=_,<@L- MI.LI:31NGC55,,`=;J<`RO#<_>F],KH6/9(QKV.#F.&0X'((5:KUPBKKWP^@ MU3<-35%5>(;6R>*`L;ZNR)L0+8FCD0=H'M=SS(YY7WZ*=]K)*J]:>FJ7OI60 MMJH(G$D1G=M?CRSEO+_]0641%\O;N8YNXMR,9'4(/"?U:"7UV>1D>QA9O>[: M`"1W/+J`LE4IXVV^LL>N'6>6_P!UNL#8HI6/N%097C=GEY=<]AU5U(OQ;/@$ M'TB+F.(5NO\`==+55OTU7>I7&9\;1.'["QF\;\'L=N>B#?/KZ*.H%,^L@;.2 M`(W2-#N?3EG*R55/C#PAM6D=-G4%KO57//%(QL\5:]CG2!QQN:0`<@XY<^7P M4F^C7?;E>M!S17*H=.:"K=30O>Y!+Z(M1J>SOOMIDM\=WN M-KX$AI/,@=>2\65U$^H-,RK@=.,@Q M-D!<,=>6%CG9$;G%P=@=LX'U(+#U592 M4;6NJZJ&`..&F60-S]:15=+,QCXJF%['DM:YKP0XCF0//H5J]5687NWP4PC@ M>Z.LII_OS<@-9,Q[P.1YEK2/FN/M&@KE;]3"X"KIQ;8JNHKX*9I(V5$WB,>< M8QCPRS`[$O\`=D.+]*__`"#3_P!,D_@4D<'"#PPTR00?^C;^\K#U;PHTYJVZ M27*]5MXF>XY9$*P^%#R`(8T@AH.,G'=;;16AK7HUDD-IKKJ^F>T-%-4U9DBC MYYRUN`&D]R$%=N!WY[ZW_P"W^(JVRBQO!+2,5TDNM+5WJEK7R/D\:GKO#='27;UQM;W9C.=@=CBI8:2DA9#3PL$<<;!AK&@8``\L(/956]*[\J[)]`=_,YQW2UQ?M!).UN0<-&>00;R#\T"NE+'71U]IKKY25 M+"/;AKBPN`(.TX`R#CF$$HHB_'MW,VX]AV"#:J"?26UE?-/4EHM5EK9J+UX2OGGA=MD+6[0&AW4']DU[04]-=3-#-3.+H*F`@/CSC<.8((.!R]R"OVH[!H.V\&H[RZXQ5^J M[I#!(V6:I,LHD+FND:UH/L@#<"2,^9SA=]Z*1'^"KN/^YG^5&MW:^!6BJ*R5 M5LF;5U4M2YIDK'O:)0&G(:T@8://`R?-;_1/#+3^BZ]];9*JZ-\1A;)#+5;H MG^\MP`2.Q[(.Z0HM5J.RQ7^V/ML];74D;W!SI**H,,AQVW#L>X05>]'-S6\6 MJ\.<`74E2&Y[GQ&G]P*VGI8_Y]I_Z)+_`!A29;N!VC[961UUOK+Y2U3#ELL- M<6.'GS#R, M'M[ES^GN#>EM.W.&Y6BMO5-41N:3LKBT2`$':X`#
-----END PRIVACY-ENHANCED MESSAGE-----